Your browser doesn't support javascript.
loading
Possibility of Immediate Introduction of a Single-Dose Antibody Induction Test as a Refinement of the NIH Test for Inactivated Rabies Vaccine Potency Determination.
Stankov, Srdan; Obradovic, Nemanja; Vujin, Dragana; Vranjes, Nenad.
Afiliación
  • Stankov S; Department of Microbiology, Pasteur Institute Novi Sad, Novi Sad, Republic of Serbia.
  • Obradovic N; Department of Microbiology, Pasteur Institute Novi Sad, Novi Sad, Republic of Serbia.
  • Vujin D; Department of Microbiology, Pasteur Institute Novi Sad, Novi Sad, Republic of Serbia.
  • Vranjes N; Department of Research and Monitoring of Rabies and Other Zoonoses, Pasteur Institute Novi Sad, Novi Sad, Republic of Serbia.
Viral Immunol ; 33(5): 367-377, 2020 06.
Article en En | MEDLINE | ID: mdl-32159457
ABSTRACT
Antibody induction test (AIT) is a promising candidate as a refinement of the troublesome National institutes of Health (NIH) test in the sense of animal welfare 3R approach for determination of potency of inactivated rabies vaccines for veterinary and human use. In this study, we initially try to develop AIT as a suitable alternative to NIH test, to achieve a reduction of test duration and diminish animal suffering by omitting intracerebral CVS infection and measuring humoral immunity upon vaccination. Designs of both multi-dose and single-dose AIT were examined. Biological reference preparation, batch 5 with assigned titer of 10 IU/vial, was taken as both standard and test vaccine. Six consecutive AITs were performed and eight pools of sera in each AIT were tested in triplicate by rapid fluorescent focus inhibition test. We estimated the upper detection limit and calculated test variability for individual dilutions. For multi-dose AIT, we estimated the dose-response function and performed calculations of final test results and statistical validity parameters for both linear and sigmoidal model using CombiStats program. Sigmoidal 4-parameter dose-response model was found optimal. Presented design of multi-dose AIT showed a satisfactory detection limit for testing of inactivated rabies vaccines for both veterinary and human use. However, due to nonconformity of obtained results with statistical validity criteria, we concluded that the presented model of multi-dose AIT was unsuitable for introduction in routine practice. However, we concluded that there was a realistic option for introduction of two versions of single-dose AIT. The first version would be with two standard vaccine controls and could be introduced immediately, while the second version would include testing of the sample only and rely on comparison of the induced rabies antibody level with absolute cut-off limits set in advance.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rabia / Vacunas Antirrábicas / Alternativas al Uso de Animales / Inmunogenicidad Vacunal / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals País/Región como asunto: America do norte Idioma: En Revista: Viral Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / VIROLOGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rabia / Vacunas Antirrábicas / Alternativas al Uso de Animales / Inmunogenicidad Vacunal / Anticuerpos Antivirales Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Animals País/Región como asunto: America do norte Idioma: En Revista: Viral Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / VIROLOGIA Año: 2020 Tipo del documento: Article